Lilly has launched TuneLab, giving biotech companies access to AI-powered drug discovery models based on over £1bn in research investment.

MSD has agreed to acquire UK biopharma company Verona Pharma in a $10bn deal, strengthening its cardio-pulmonary care portfolio.

A group of 300 middle schoolers are named in the 2025 Thermo Fisher Junior Innovators Challenge for STEM projects in AI to climate change.

The National Institute for Health and Care Research (NIHR) is funding Newcastle Univeristy’s work in emerging diagnostics, devices and more.

A £29.6 million government investment will establish the UK RNA Biofoundry in Darlington, providing manufacturing capacity to accelerate RNA therapies from lab to clinic.

Novo Nordisk partners with Replicate Bioscience in a $550M srRNA deal to develop new therapies for obesity, diabetes and cardiometabolic diseases.

From the latest in clinical evidence to new investments, there’s plenty to uncover.

AbbVie has announced the acquisition of Gilgamesh Pharmaceuticals’ lead investigational drug – a next-generation psychedelic compound for moderate-to-severe major depressive disorder.